Senate panel appropriates $2.04 billion for FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA will have $2.04 billion in appropriations for fiscal 2009, including $278.4 million for the device center and related field activities, under an Agriculture bill that passed the Senate Appropriations Committee July 17. The bill would give FDA $324.6 million more than it received this year, and $5.2 million more than the Bush administration's request. CDRH would gain $40.4 million more in FY 2009 appropriations over fiscal '08, and $1 million more than the president requested. The bill anticipates $52.5 million in device user fee funding for FY 2009. With the expanded FDA funding, the committee wants $104 million spent for device, drug and biologic safety to increase overseas and domestic inspections and $40 million to upgrade science programs across the agency. The House Appropriations Committee has yet to sign off on funding levels, and Chairman David Obey, D-Wis., previously suggested resorting to continuing resolutions 1("The Gray Sheet" July 7, 2008, p. 9)
You may also be interested in...
FY 2009 FDA Appropriations Will Likely Have To Wait For Next Administration
House Democratic leaders are signaling an intention to put off finalizing fiscal year 2009 appropriations at least until next March, charging Republican members of Congress and the Bush administration with standing in the way of negotiating mutually agreeable bills
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.